Athira Pharma, Inc. (ATHA)

NASDAQ

$--

(--)

Regular Market

Athira Pharma, Inc. (ATHA) Live Price Chart

Last updated: ⁦2026-10-21 14:57:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Athira Pharma, Inc. (ATHA) operates in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Athira Pharma, Inc. (ATHA) Stock Price Today

Athira Pharma, Inc. (ATHA) is currently trading at $-- as of --, -- from the previous close of $--

During today's regular trading session, ATHA has traded between $-- and $--, with a trading volume of -- shares. The current price is -- of today's range.

Athira Pharma, Inc. (ATHA) 7-Day Stock Price Change

Over the past seven days, Athira Pharma, Inc. (ATHA) moved from $7.09 to $6.75, representing a decline of 4.80% ($0.34).

The stock traded between $6.41 and $7.64 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 131.56 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

What is Athira Pharma, Inc. (ATHA)?

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Athira Pharma, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Employees	26
Exchange	NASDAQ
Company Website	https://www.athira.com

How to Buy Athira Pharma, Inc. (ATHA) Stock on MEXC

Eligible investors can buy real shares of Athira Pharma, Inc. (ATHA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ATHA and Place Your Order

Open the RealStocks trading page and search for ATHA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Athira Pharma, Inc. (ATHA) stock price today?

Athira Pharma, Inc. (ATHA) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is ATHA stock going up or down today?

As of --, ATHA is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is ATHA pre-market price?

As of --, ATHA is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ATHA after-hours price?

As of --, ATHA is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ATHA stock trading now?

ATHA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ATHA sit relative to its 52-week high and low?

Over the past 52 weeks, ATHA has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Athira Pharma, Inc. in?

Athira Pharma, Inc. (ATHA) operates in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Athira Pharma, Inc.'s market capitalization and where is it listed?

Athira Pharma, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ATHA valued in terms of P/E ratio and EPS?

ATHA trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Athira Pharma, Inc. pay a dividend?

Athira Pharma, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.